This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This edition reflects the new program of the Council on Pharmacy and Chemistry, which involves expansion of evaluation of drugs, replacing the former procedure of accepting individual formulations of manufacturers for inclusion in the book. All evaluated drugs are described under generic ( nonproprietary ) names in the form of monographs, which follow essentially the style of former editions. To aid physicians and others interested, such trade names as are known to the Council appear at the end of each monograph. Both generic and trade names appear in the index, which is complete and well arranged. A concise statement of the principles governing the program of evaluation is included in the preface. Fifty-eight new monographs have been added to this edition. Among the more notable are those for alseroxylon and reserpine of the Rauwolfia group of alkaloids, chlorpromazine, fludrocortisone, prednisolone and prednisone, nystatin, and warfarin. The volume is a striking illustration of
New and Nonofficial Remedies: Containing Descriptions of Drugs Evaluated by the Council on Pharmacy and Chemistry of the American Medical Association, 1956. JAMA. 1956;161(17):1716. doi:10.1001/jama.1956.02970170112030
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: